0001600132-20-000104.txt : 20200914 0001600132-20-000104.hdr.sgml : 20200914 20200914160401 ACCESSION NUMBER: 0001600132-20-000104 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200910 FILED AS OF DATE: 20200914 DATE AS OF CHANGE: 20200914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wang Theodore T CENTRAL INDEX KEY: 0001694061 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 201173218 MAIL ADDRESS: STREET 1: C/O PUISSANCE CAPITAL MANAGEMENT LP STREET 2: 950 THIRD AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 4 1 wf-form4_160011382783695.xml FORM 4 X0306 4 2020-09-10 0 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001694061 Wang Theodore T C/O PUISSANCE CAPITAL MANAGEMENT LP 950 THIRD AVENUE, 25TH FLOOR NEW YORK NY 10022 1 0 1 0 Stock Option (right to buy) 10.12 2020-09-10 4 A 0 6509 10.12 A 2021-09-10 2030-09-10 Common Stock 6509.0 13806 D /s/ Theodore T. Wang 2020-09-14